Please use this identifier to cite or link to this item:
Title: Pharmacokinetics and Pharmacodynamics of Conventional-Dose vs Triple-Dose Oseltamivir in Severely Immunocompromised Children With Influenza.
Issue Date: 23-Oct-2019
Citation: Open Forum Infect Dis.2019;(6)10:ofz430
Abstract: This randomized phase 1b study evaluated the pharmacokinetics/pharmacodynamics of conventional-dose (30-75 mg twice daily [BID]) vs triple-dose (90-225 mg BID; weight-adjusted) oseltamivir for treatment of influenza in severely immunocompromised children
PMID: 31660381
Rights: openAccess
ISSN: 2328-8957
Appears in Collections:Fundaciones e Institutos de Investigación > FIB H. Infantil U. Niño Jesús > Artículos
Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos
Hospitales > H. U. Gregorio Marañón > Artículos

Files in This Item:
File SizeFormat 
PMC6809794.pdf385.94 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons